Literature DB >> 23715661

Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.

Nathella Pavan Kumar1, Rathinam Sridhar, Vaithilingam V Banurekha, Mohideen S Jawahar, Thomas B Nutman, Subash Babu.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (DM) is a major risk factor for the development of active pulmonary tuberculosis, although the immunological mechanisms underlying this interaction remain unexplored. The influence of poorly controlled diabetes on pathogen-specific T-helper 1 (Th1) and T-helper 17 (Th17) responses have not been examined.
METHODS: To identify the role of Th1 and Th17 cells in tuberculosis with coincident DM, we examined mycobacteria-specific immune responses in the whole blood of individuals who had tuberculosis with DM and compared them to those in individuals who had tuberculosis without DM.
RESULTS: Tuberculosis coincident with DM is characterized by elevated frequencies of monofunctional and dual-functional CD4(+) Th1 cells following Mycobacterium tuberculosis antigen stimulation and elevated frequencies of Th17 subsets at both baseline and following antigen stimulation. This was associated with increased systemic (plasma) levels of both Th1 and Th17 cytokines and decreased baseline frequencies of natural regulatory T cells but not interleukin 10 or transforming growth factor β.
CONCLUSIONS: Therefore, our data reveal that tuberculosis in persons with DM is characterized by elevated frequencies of Th1 and Th17 cells, indicating that DM is associated with an alteration in the immune response to tuberculosis, leading to a biased induction of Th1- and Th17-mediated cellular responses and likely contributing to increased immune pathology in M. tuberculosis infection.

Entities:  

Keywords:  T cells; bacterial; cytokines; diabetes mellitus; tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23715661      PMCID: PMC3733509          DOI: 10.1093/infdis/jit241

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.

Authors:  A M Caruso; N Serbina; E Klein; K Triebold; B R Bloom; J L Flynn
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.

Authors:  Shabaana A Khader; Guy K Bell; John E Pearl; Jeffrey J Fountain; Javier Rangel-Moreno; Garth E Cilley; Fang Shen; Sheri M Eaton; Sarah L Gaffen; Susan L Swain; Richard M Locksley; Laura Haynes; Troy D Randall; Andrea M Cooper
Journal:  Nat Immunol       Date:  2007-03-11       Impact factor: 25.606

Review 3.  Immune dysfunction in patients with diabetes mellitus (DM).

Authors:  S E Geerlings; A I Hoepelman
Journal:  FEMS Immunol Med Microbiol       Date:  1999-12

Review 4.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

Review 5.  Is type II diabetes mellitus a disease of the innate immune system?

Authors:  J C Pickup; M A Crook
Journal:  Diabetologia       Date:  1998-10       Impact factor: 10.122

6.  Tuberculosis and diabetes in southern Mexico.

Authors:  Alfredo Ponce-De-Leon; Ma de Lourdes Garcia-Garcia Md; Ma Cecilia Garcia-Sancho; Francisco J Gomez-Perez; Jose Luis Valdespino-Gomez; Gustavo Olaiz-Fernandez; Rosalba Rojas; Leticia Ferreyra-Reyes; Bulmaro Cano-Arellano; Miriam Bobadilla; Peter M Small; Jose Sifuentes-Osornio
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

7.  The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I).

Authors:  M Deepa; R Pradeepa; M Rema; Anjana Mohan; R Deepa; S Shanthirani; V Mohan
Journal:  J Assoc Physicians India       Date:  2003-09

8.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  58 in total

1.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

2.  Special computer-aided computed tomography (CT) volume measurement and comparison method for pulmonary tuberculosis (TB).

Authors:  Jingming Liu; Zhaogang Sun; Ruming Xie; Mengqiu Gao; Chuanyou Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

4.  Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

Authors:  Kirsten A Kulcsar; Christopher M Coleman; Sarah E Beck; Matthew B Frieman
Journal:  JCI Insight       Date:  2019-10-17

5.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

Review 6.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 7.  Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?

Authors:  M Alexander; A Gupta; J S Mathad
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

8.  Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Parakkal Jovvian George; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

Review 9.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

Review 10.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.